XTL Biopharmaceuticals (XTLB) - Earnings growth in current year
Risks for XTL Biopharmaceuticals (XTLB) are linked to a lack of revenue and the integration of AI medicine, which is reflected in the annual EPS growth rate on the GURU.Markets chart, where the metric remains around 0.00. The firm's potential is based on the development of antibodies against systemic lupus erythematosus. The success of such innovations will provide the company with monopoly pricing power over unique therapies for autoimmune pathologies.
Comprehensive metric breakdowns and analytics for XTL Biopharmaceuticals (XTLB)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Debt to Equity Ratio XTL Biopharmaceuticals|XTLB - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio XTL Biopharmaceuticals Ltd|XTLB - Company Debts|Debt to Book Capitalization Ratio XTL Biopharmaceuticals Ltd|XTLB - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings XTL Biopharmaceuticals|Quick Liquidity xtlbio.com
- earnings and market ratios statistics:
XTLB - Net Profit|Company Profit Forecast XTL Biopharmaceuticals|XTLB - Price to Earnings Ratio|Projected Price to Earnings Ratio xtlbio.com|XTLB - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio XTL Biopharmaceuticals|XTLB - Operating profit EBITDA|Earnings per share for the trailing year XTL Biopharmaceuticals|XTLB - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth xtlbio.com|XTLB - Earnings per share growth in current year|Expected earnings per share trend next year XTL Biopharmaceuticals
- sales volume and revenue information:
Basic company analysis:XTL Biopharmaceuticals, XTLB
This metric is calculated as the percentage deviation of current earnings per share from the value of the same period last year. This metric measures the growth rate of net yield, allowing for an assessment of business scaling efficiency. For XTL Biopharmaceuticals (XTLB), the EPS trend reflects the financial implications of developing therapies for immunological diseases. By analyzing the history of annual changes in earnings per share, an investor can identify the commercialization potential of innovative assets.
Key competitors
Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year IMVT (immunovant.com)|Kiniksa Corp (KNSA) - Earnings per share growth rate in current year|Grifols Biemat - Earnings growth in current year|ADPT - Earnings growth in current year|CLDX: Earnings growth in current year|Aurinia Pharmaceuticals Inc (AUPH) - Earnings growth in current year|Earnings per share growth in current year biocryst.com|VERA: Earnings per share increase in current year|Earnings per share growth in current year Dianthus Therapeutics, Inc. (DNTH)|PHVS (Pharvaris) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera ABCL|TRML - Net earnings per share growth this year|Precigen Inc - Earnings growth in current year|Expected net earnings per share growth this year Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Net earnings per share growth this year|Net earnings per share growth this year Upstream Bio|ZBIO (Zenas Bio) - Earnings growth in current year|Earnings per share growth rate in current year Immunome Corp IMNM|Net earnings per share growth this year GOSS (Gossamer Corp)|KALV (KalVista Corp) - Earnings per share increase in current year|Earnings growth in current year SEPN (septerna.com)|Earnings growth in current year pieris.com PVLA|SVRA: Net earnings per share growth this year|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth this year|ANAB: Earnings growth in current year|Astria Corp (ATXS) - Earnings growth in current year|Earnings per share growth in current year enGene|Earnings growth in current year RAPT Therapeutics|Earnings growth in current year JBIO|ACRS: Earnings per share trend in current year|Earnings growth in current year KYTX (kyvernatx.com)|TLSA - Net earnings per share growth this year|CABA - Earnings per share growth in current year|Ventyx Biosciences (VTYX) - Net earnings per share growth this year|Theratechnologies, Inc. (THTX) - Earnings per share growth in current year|Net earnings per share growth this year Avalo Therapeutics, Inc.|ELDN (Eledon Pharmaceuticals, Inc) - Earnings growth in current year|Agenus, Inc (AGEN) - Expected net earnings per share growth this year|Earnings growth in current year CLYM|ZURA (Zura Bio Limited) - Earnings per share increase in current year|Earnings per share growth in current year aTyr Pharma ATYR|ADAG - Net earnings per share growth this year|IMA - Earnings per share growth in current year|Shattuck Labs - Net earnings per one share growth for the current year|EQ: Earnings growth in current year|Earnings per share trend in current year CNTB (Connect Biopharma Holdings)|Net earnings per share growth this year IMUX|ATRA (atarabio.com) - Net earnings per one share growth for the current year|Earnings growth in current year IFRX|Earnings growth in current year X4 Pharma (XFOR)|Adicet Bio Inc. - Net earnings per share growth this year|Earnings growth in current year celularity.com CELU|INMB: Net earnings per share growth this year|BRNS: Earnings per share growth in current year|KZR: Earnings growth in current year|SAB Biotherapeutics Inc - Earnings per share increase in current year|AKTX (Akari Therapeutics, Plc) - Earnings growth in current year|ENLV: Earnings per share increase in current year|Earnings per share growth in current year Q32 Bio (QTTB)|Net earnings per share growth this year GeoVax Labs GOVX|Earnings growth in current year EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Earnings per share growth rate in current year|CARM: Net earnings per share growth this year|Earnings per share increase in current year BOLT (boltbio.com)|HCW Biologics Inc (HCWB) - Earnings per share growth in current year|Net earnings per share growth this year Aptevo|Net earnings per share growth this year AIM|Earnings per share growth this year ADTX (aditxt.com)|Earnings per share growth in current year GRI Bio Inc (GRI)|XRTX (XORTX Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year HIND (Vyome Therapeutics)|REVB - Net earnings per share growth this year|INDP: Net earnings per share growth this year|Earnings per share increase in current year SCNI (Scinai)|CALI: Earnings growth in current year|Affimed NV - Earnings per share increase in current year|ALLK (Allakos) - Earnings growth in current year|Earnings per share growth rate in current year hookipapharma.com HOOK|Earnings growth in current year IGMS|ITOS - Earnings per share growth rate in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year
